RxDoctor Payments Data

Stephanie Staatz

Optometrist · Parkville, MONPI 1093747305

Payments from drug & device makers

$2,816in general payments, 2019–2025

Across 94 payments — averaging $29.96 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Johnson & Johnson Vision Care, Inc.$2K
  • Alcon$444
  • Glaukos Corporation$190
  • Sight Sciences, Inc.$151
  • AbbVie$128
  • Amgen$120
  • plus $201 from 5 others
$108in research payments, 2019–2025

Across 1 payment — averaging $108.30 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • AbbVie$108

What the payments were for

  • Food & beverage$2,76298%
  • Entertainment$542%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$2,816 in reported general payments places this provider in the 80th percentile of 1,030 optometrist providers in Missouri.

See all optometrist providers in Missouri

Medicare billing

Part B allowed, 2024
$21,817
Medicare patients
142
Services billed
232

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Timolol Maleate12$46

Paid to pharmacies, not to this prescriber.

Other optometrist in Parkville

See the full list for Missouri

Where these figures come from

Is this you, or does something look wrong? →